Soluble is a developer of reagent kits providing formulation optimization solutions for protein-based therapeutics... Read more
Soluble is a developer of reagent kits providing formulation optimization solutions for protein-based therapeutics... Read more
News
Jul 06, 2020
Network Newswire
Press Release: Soluble Therapeutics : Predictive Oncology Inc. (NASDAQ: POAI) Announces Acquisition of Soluble Therapeutics, BioDtech as it Continues Buildout of Precision Medicine Business - NetworkNewsWire
Jun 02, 2020
BioSpace
Soluble Therapeutics: Predictive Oncology Completes Acquisition of Soluble Therapeutics and BioDtech
May 14, 2020
GlobeNewswire
Press Release: Soluble Therapeutics : Predictive Oncology (NASDAQ Symbol POAI) is licensing and partnering this groundbreaking NSP10 technology in the race to develop a vaccine for development
Jan 04, 2017
The Business Journals
Soluble Therapeutics: Soluble Therapeutics CEO announces biotech consulting venture
Dec 20, 2016
Texas TechPulse
Soluble Therapeutics: CytoBioscience Buys Soluble Therapeutics
Dec 20, 2016
The Business Journals
Soluble Therapeutics: Birmingham biotech startup acquired by San Antonio company
Dec 19, 2016
Xconomy
Soluble Therapeutics: CytoBiosciences Buys Alabama Company in 'Multi-Million Dollar' Deal
Apr 17, 2015
BIRMINGHAM BUSINESS JOURNAL
Soluble Therapeutics: Soluble Therapeutics receives $150K NIH grant to extend tech capabilities
Oct 02, 2014
BIRMINGHAM BUSINESS JOURNAL
Soluble Therapeutics: Soluble Therapeutics acquires Seattle-based biotech company
Soluble Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10